Prophylaxis: a strategy to minimise antiviral resistance.
D000212:Acyclovir / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D005260:Female; D006561:Herpes Simplex / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D009154:Mutation; D011292:Premedication; D018139:Simplexvirus / Q000187:drug effects; D013937:Thymidine Kinase / Q000172:deficiency / Q000235:genetics; D014777:Virus Diseases / Q000188:drug therapy / Q000517:prevention & control*; D014780:Viruses / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics
D000998:Antiviral Agents; C025114:acyclovir triphosphate; D013937:Thymidine Kinase; D000212:Acyclovir